T cell responses are regulated by co-stimulatory and inhibitory signalling pathways, driven by receptors and their ligands designated as immune checkpoints. These receptors belong either to the ...
BRANFORD, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to ...
A new review charts how immune cell engagers, from bispecific antibodies and aptamers to surface-engineered cells and ...
Understanding how immune cells coordinate within the tumor microenvironment is essential for developing effective cancer immunotherapies. While CD8⁺ cytotoxic T cells are central to anti-tumor ...
A Nature Reviews Cancer review argues that metabolism, from CAR design and manufacturing conditions to the patient's diet, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results